{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:19:18Z","timestamp":1790104758282,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["27378"],"award-info":[{"award-number":["27378"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2022"],"award-info":[{"award-number":["IG 2022"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejphar.2026.178960","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:57:30Z","timestamp":1778284650000},"page":"178960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["SAHA induces immunogenic cell death in triple negative breast cancer cells and its efficacy is enhanced by SOCS3 functional replacement"],"prefix":"10.1016","volume":"1026","author":[{"given":"Giuliano","family":"Castellano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candida","family":"Bucciero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cugudda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7762-0708","authenticated-orcid":false,"given":"Sara","family":"La Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Marasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8276-9769","authenticated-orcid":false,"given":"Giuseppe","family":"Portella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Malfitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178960_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13287-023-03320-9","article-title":"Targeting G-quadruplex motifs interferes with differentiation of adipose-derived mesenchymal stem cells","volume":"14","author":"Ambrosio","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ejphar.2026.178960_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer - expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.178960_bib3","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1038\/cddis.2013.9","article-title":"HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses","volume":"4","author":"Bolden","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2026.178960_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076340","article-title":"Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo","volume":"8","author":"Chiu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178960_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081643","article-title":"Immuno-modulatory and anti-inflammatory effects of dihydrogracilin A, a terpene derived from the marine sponge Dendrilla membranosa","volume":"18","author":"Ciaglia","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178960_bib6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ni931","article-title":"SOCS3 negatively regulates IL-6 signaling in vivo","volume":"4","author":"Croker","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2026.178960_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111797","article-title":"G-Quadruplex binders induce immunogenic cell death markers in aggressive breast cancer cells","volume":"11","author":"Di Somma","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.178960_bib8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3389\/fonc.2019.00564","article-title":"The oncolytic virus dl922-947 triggers immunogenic cell death in mesothelioma and reduces xenograft growth","volume":"9","author":"Di Somma","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2026.178960_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040829","article-title":"Platinum(II) O,S complexes inhibit the aggregation of amyloid model systems","volume":"20","author":"Florio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178960_bib10","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.18632\/oncotarget.7180","article-title":"Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells","volume":"7","author":"Gameiro","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2026.178960_bib11","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4155\/fmc.12.80","article-title":"Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives","volume":"4","author":"Giannini","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178960_bib12","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/1878-0261.13585","article-title":"Enhancing therapeutic efficacy in triple-negative breast cancer and melanoma: synergistic effects of modulated electro-hyperthermia (mEHT) with NSAIDs especially COX-2 inhibition in in vivo models","volume":"18","author":"Giunashvili","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejphar.2026.178960_bib13","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"Embo j"},{"key":"10.1016\/j.ejphar.2026.178960_bib14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI200111537","article-title":"Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia","volume":"108","author":"He","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.178960_bib15","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.7150\/thno.26627","article-title":"Novel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling","volume":"8","author":"Huang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2026.178960_bib16","doi-asserted-by":"crossref","first-page":"12346","DOI":"10.1021\/acs.jmedchem.2c01058","article-title":"Discovery of a novel G-Quadruplex and histone deacetylase (HDAC) dual-targeting agent for the treatment of triple-negative breast cancer","volume":"65","author":"Jiang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178960_bib17","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1200\/JCO.2005.14.167","article-title":"Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer","volume":"23","author":"Kelly","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.178960_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/onc.2014.4","article-title":"SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model","volume":"34","author":"Kim","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2026.178960_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14164027","article-title":"Identification of lethal inhibitors and inhibitor combinations for mono-driver versus multi-driver triple-negative breast cancer cells","volume":"14","author":"Ku","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.178960_bib20","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.2147\/IJN.S441205","article-title":"PEGylated SOCS3 mimetics encapsulated into PLGA-NPs as selective inhibitors of JAK\/STAT pathway in TNBC cells","volume":"19","author":"La Manna","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejphar.2026.178960_bib21","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1021\/acs.inorgchem.3c01522","article-title":"Metal-complexes bearing releasable CO differently modulate amyloid aggregation","volume":"62","author":"La Manna","year":"2023","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejphar.2026.178960_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000195","article-title":"Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis","volume":"8","author":"Laengle","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejphar.2026.178960_bib23","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s42003-021-02741-7","article-title":"LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer","volume":"4","author":"Li","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejphar.2026.178960_bib24","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1021\/acs.jmedchem.0c02111","article-title":"Discovery of novel Pyrrolo[2,3-d]pyrimidine-based derivatives as potent JAK\/HDAC dual inhibitors for the treatment of refractory solid tumors","volume":"65","author":"Liang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178960_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13058-023-01642-3","article-title":"Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6\/STAT3 signaling","volume":"25","author":"Liu","year":"2023","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejphar.2026.178960_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178079","article-title":"Targeting STAT3 pathway: a promising immunotherapeutic strategy for triple-negative breast cancer - current status and future outlooks","volume":"1005","author":"Malekinejad","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178960_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062511","article-title":"Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis","volume":"8","author":"Malfitano","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178960_bib28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.bjp.0707651","article-title":"Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells","volume":"153","author":"Malfitano","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178960_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1574889810666160421121726","article-title":"Immuno-modulatory properties of a Quinolin-2-(1H)-on-3-Carboxamide derivative: relevance in multiple sclerosis","volume":"10","author":"Malfitano","year":"2016","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.ejphar.2026.178960_bib30","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.ejphar.2026.178960_bib31","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1158\/0008-5472.CAN-16-2247","article-title":"HDAC inhibitor panobinostat engages host innate immune defenses to promote the tumoricidal effects of trastuzumab in HER2(+) tumors","volume":"77","author":"Medon","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.178960_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13058-015-0534-y","article-title":"Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells","volume":"17","author":"Min","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejphar.2026.178960_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117245","article-title":"Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer","volume":"285","author":"Moraca","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178960_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162482","article-title":"Combination of dl922-947 oncolytic adenovirus and G-Quadruplex binders uncovers improved antitumor activity in breast cancer","volume":"11","author":"Napolitano","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.178960_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12964-025-02174-3","article-title":"Reversal of epithelial to mesenchymal transition in triple negative breast cancer through epigenetic modulations by dietary flavonoid galangin and its combination with SAHA","volume":"23","author":"Nimal","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejphar.2026.178960_bib36","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.1038\/s41598-024-60395-x","article-title":"Apigenin and its combination with vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs","volume":"14","author":"Nimal","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178960_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-020-06033-2","article-title":"HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells","volume":"186","author":"Oba","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejphar.2026.178960_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122751","article-title":"PGE2 induced miR365\/IL-6\/STAT3 signaling mediates dendritic cell dysfunction in cancer","volume":"350","author":"Pandey","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.178960_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106926","article-title":"The combination of the HDAC1 inhibitor SAHA and doxorubicin has synergic efficacy in triple negative breast cancer in vivo","volume":"196","author":"Pang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.178960_bib40","doi-asserted-by":"crossref","first-page":"e2740","DOI":"10.1038\/cddis.2017.158","article-title":"Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer","volume":"8","author":"Shen","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2026.178960_bib41","doi-asserted-by":"crossref","first-page":"114156","DOI":"10.18632\/oncotarget.23169","article-title":"HDAC inhibition potentiates immunotherapy in triple negative breast cancer","volume":"8","author":"Terranova-Barberio","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2026.178960_bib42","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/carcin\/bgt033","article-title":"Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells","volume":"34","author":"Vasilatos","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2026.178960_bib43","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.ymthe.2024.03.025","article-title":"SOCS3 regulates pathological retinal angiogenesis through modulating SPP1 expression in microglia and macrophages","volume":"32","author":"Wang","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2026.178960_bib44","doi-asserted-by":"crossref","first-page":"8345","DOI":"10.2147\/CMAR.S210029","article-title":"Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties","volume":"11","author":"Wawruszak","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ejphar.2026.178960_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143013","article-title":"Assessment of interactions between cisplatin and two histone deacetylase inhibitors in MCF7, T47D and MDA-MB-231 human breast cancer cell lines - an isobolographic analysis","volume":"10","author":"Wawruszak","year":"2015","journal-title":"PLoS One"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926004425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926004425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:51:44Z","timestamp":1783057904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926004425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":45,"alternative-id":["S0014299926004425"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178960","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SAHA induces immunogenic cell death in triple negative breast cancer cells and its efficacy is enhanced by SOCS3 functional replacement","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178960"}}